Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Current Leases (2020 - 2025)

Historic Current Leases for Dare Bioscience (DARE) over the last 6 years, with Q3 2025 value amounting to $1.9 million.

  • Dare Bioscience's Current Leases rose 26960.88% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 26960.88%. This contributed to the annual value of $548638.0 for FY2024, which is 1704.88% up from last year.
  • As of Q3 2025, Dare Bioscience's Current Leases stood at $1.9 million, which was up 26960.88% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Current Leases registered a high of $1.9 million during Q3 2025, and its lowest value of $195000.0 during Q3 2023.
  • In the last 5 years, Dare Bioscience's Current Leases had a median value of $419000.0 in 2021 and averaged $612843.3.
  • In the last 5 years, Dare Bioscience's Current Leases tumbled by 4975.97% in 2023 and then skyrocketed by 27521.45% in 2025.
  • Dare Bioscience's Current Leases (Quarter) stood at $270546.0 in 2021, then surged by 47.25% to $398391.0 in 2022, then rose by 17.65% to $468726.0 in 2023, then rose by 17.05% to $548638.0 in 2024, then soared by 240.77% to $1.9 million in 2025.
  • Its Current Leases stands at $1.9 million for Q3 2025, versus $1.8 million for Q2 2025 and $1.8 million for Q1 2025.